X0306 4 2021-06-03 false 0001636422 Health Catalyst, Inc. HCAT 0001780878 Llewelyn Linda C/O HEALTH CATALYST, INC. 10897 SOUTH RIVER FRONT PARKWAY, #300 SOUTH JORDAN UT 84095 false true false false Chief People Officer Common Stock 2021-06-03 4 M false 1100.00 10.80 A 41457.00 D Common Stock 2021-06-03 4 M false 1100.00 11.78 A 42557.00 D Common Stock 2021-06-03 4 S false 3186.00 52.7748 D 39371.00 D Stock Option (Right to Buy) 11.78 2021-06-03 4 M false 1100.00 0.00 D 2028-01-24 Common Stock 1100.00 13554.00 D Stock Option (Right to Buy) 10.80 2021-06-03 4 M false 1100.00 0.00 D 2028-09-27 Common Stock 1100.00 33098.00 D The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 9, 2020, in accordance with Rule 10b5-1. Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $52.16 to $53.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote. 25% of the 17,954 shares underlying the options vested in an annual installment on January 24, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on January 24, 2022. 25% of the 59,351 shares underlying the options vested in an annual installment on September 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022. /s/ Daniel Orenstein, as Attorney-in-Fact 2021-06-07